Peter G Kremsner Selected Research

Parasitic Diseases (Parasitic Disease)

1/2019	Ivermectin Impairs the Development of Sexual and Asexual Stages of Plasmodium falciparum In Vitro.
3/2013	Efficacy of mefloquine intermittent preventive treatment in pregnancy against Schistosoma haematobium infection in Gabon: a nested randomized controlled assessor-blinded clinical trial.
6/2007	Higher production of peripheral blood macrophage migration inhibitory factor in healthy children with a history of mild malaria relative to children with a history of severe malaria.
5/2006	Decreased circulating macrophage migration inhibitory factor (MIF) protein and blood mononuclear cell MIF transcripts in children with Plasmodium falciparum malaria.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peter G Kremsner Research Topics

Disease

166	Malaria 05/2024 - 01/2002
95	Infections 05/2024 - 04/2002
50	Falciparum Malaria (Plasmodium falciparum Malaria) 01/2021 - 01/2003
16	Parasitemia 01/2021 - 02/2003
14	COVID-19 02/2024 - 01/2021
12	Hepatitis B 12/2022 - 01/2003
11	Body Weight (Weight, Body) 01/2021 - 01/2002
9	Anemia 12/2019 - 10/2003
8	Schistosomiasis (Bilharziasis) 10/2022 - 03/2004
7	Fever (Fevers) 03/2024 - 06/2005
7	Communicable Diseases (Infectious Diseases) 05/2021 - 01/2003
6	Hemolysis 12/2019 - 01/2002
5	Disease Progression 01/2021 - 09/2003
5	Sickle Cell Trait 01/2020 - 05/2003
5	Neoplasms (Cancer) 01/2020 - 01/2015
5	Cerebral Malaria 02/2019 - 10/2002
5	Hepatocellular Carcinoma (Hepatoma) 09/2016 - 09/2003
4	Pain (Aches) 03/2024 - 06/2005
4	Schistosomiasis haematobia (Schistosomiasis haematobium) 10/2022 - 03/2015
4	Liver Diseases (Liver Disease) 01/2020 - 01/2015
4	Reinfection 12/2019 - 07/2004
4	Parasitic Diseases (Parasitic Disease) 01/2019 - 05/2006
3	Gastroenteritis 04/2024 - 11/2021
3	Inflammation (Inflammations) 12/2023 - 12/2009
3	Pulmonary Tuberculosis 08/2022 - 07/2005
3	Vesicular Stomatitis 01/2022 - 04/2016
3	Hypoxia (Hypoxemia) 01/2021 - 07/2010
3	Hemolytic Anemia 01/2021 - 12/2014
3	Liver Cirrhosis (Hepatic Cirrhosis) 09/2016 - 09/2003
3	Chronic Hepatitis B 09/2016 - 06/2004
3	Bites and Stings (Sting) 08/2015 - 02/2015

Drug/Important Bio-Agent (IBA)

42	VaccinesIBA 05/2024 - 11/2002
25	AntigensIBA 03/2024 - 12/2002
23	ArtesunateIBA 12/2019 - 11/2002
22	Proteins (Proteins, Gene)FDA Link 05/2022 - 12/2002
21	Antimalarials (Antimalarial Agents)IBA 12/2023 - 03/2003
21	artemisinin (artemisinine)IBA 10/2022 - 12/2002
20	AntibodiesIBA 01/2022 - 12/2002
19	1- acetyl- 1,2,3,3a,8,8a- hexahydro- 8a- hydroxy- 5- methoxypyrrolo(2,3- b)indole (CHMI)IBA 05/2024 - 03/2015
17	CytokinesIBA 11/2020 - 04/2002
16	Immunoglobulin G (IgG)IBA 01/2022 - 12/2002
14	Malaria VaccinesIBA 01/2022 - 06/2005
11	Mefloquine (Lariam)FDA LinkGeneric 01/2019 - 01/2002
11	pyrimethamine drug combination fanasil (Fansidar)FDA Link 01/2019 - 10/2006
11	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2011 - 05/2003
9	Chloroquine (Aralen)FDA LinkGeneric 05/2024 - 03/2005
9	fosmidomycinIBA 01/2018 - 12/2002
9	Interleukin-10 (Interleukin 10)IBA 01/2012 - 04/2002
8	Hemoglobins (Hemoglobin)IBA 12/2019 - 10/2003
8	Surface Antigens (Surface Antigen)IBA 01/2019 - 12/2002
8	Clindamycin (Cleocin)FDA LinkGeneric 10/2016 - 03/2004
7	EnzymesIBA 01/2022 - 06/2008
7	Membrane Proteins (Integral Membrane Proteins)IBA 01/2022 - 12/2002
7	Amodiaquine (Camoquin)FDA Link 12/2019 - 04/2003
7	Quinine (Quinson)FDA Link 03/2015 - 12/2002
7	hemozoinIBA 11/2009 - 01/2004
6	Interleukin-6 (Interleukin 6)IBA 12/2023 - 09/2003
6	DNA (Deoxyribonucleic Acid)IBA 12/2022 - 06/2004
6	Messenger RNA (mRNA)IBA 01/2022 - 05/2006
6	InterferonsIBA 01/2021 - 09/2003
6	Interferon-gamma (Interferon, gamma)IBA 01/2011 - 05/2005
5	Merozoite Surface Protein 1 (MSA1)IBA 04/2024 - 04/2003
5	Biomarkers (Surrogate Marker)IBA 01/2024 - 04/2010
5	ImmunosorbentsIBA 01/2022 - 06/2008
5	TabletsIBA 01/2021 - 12/2003
5	RNA (Ribonucleic Acid)IBA 01/2021 - 02/2009
5	LipidsIBA 01/2020 - 12/2002
5	proguanil drug combination atovaquone (malarone)FDA Link 01/2018 - 11/2002
5	ferroquineIBA 08/2017 - 12/2006
5	ArtemisininsIBA 01/2017 - 06/2005
5	Mannose-Binding Lectin (Mannan-Binding Lectin)IBA 12/2015 - 01/2003
5	InterleukinsIBA 01/2011 - 09/2003
4	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 02/2024 - 01/2021
4	LigandsIBA 01/2022 - 03/2004
4	aluminum sulfate (alum)IBA 01/2021 - 06/2005
4	Transcription Factors (Transcription Factor)IBA 11/2020 - 01/2003
4	Lumefantrine Drug Combination Artemether (Coartem)FDA Link 12/2019 - 07/2012
4	Complement System Proteins (Complement)IBA 11/2018 - 11/2009
4	Peptides (Polypeptides)IBA 01/2015 - 07/2003
3	Ivermectin (Mectizan)FDA Link 03/2024 - 01/2019
3	artesunate drug combination pyronaridine tetraphosphateIBA 12/2023 - 09/2008
3	Hepatitis B Surface Antigens (HBsAg)FDA Link 12/2022 - 01/2013
3	Indicators and Reagents (Reagents)IBA 01/2021 - 09/2006
3	Transaminases (Aminotransferases)IBA 01/2021 - 01/2003
3	Rabies Vaccines (Rabies Vaccine)FDA Link 01/2021 - 01/2011
3	CholesterolIBA 01/2020 - 12/2002
3	oxidized low density lipoproteinIBA 01/2020 - 12/2002
3	Aluminum Hydroxide (Algeldrate)FDA Link 10/2019 - 01/2016
3	Panton-Valentine leukocidinIBA 01/2019 - 05/2011
3	LectinsIBA 12/2015 - 06/2013
3	ChemokinesIBA 02/2015 - 07/2005
3	Immunoglobulin E (IgE)IBA 04/2012 - 03/2004
3	Interleukin-2 (IL2)IBA 04/2012 - 07/2004
3	N 30IBA 01/2011 - 07/2005
3	Interferon-alpha (Interferon Alfa)IBA 12/2008 - 10/2006

Therapy/Procedure

25	Therapeutics 10/2022 - 01/2003
5	Mass Drug Administration 07/2021 - 05/2014
5	Blood Transfusion (Blood Transfusions) 01/2021 - 04/2010
5	Chemoprevention 01/2021 - 12/2007
5	Aftercare (After-Treatment) 08/2015 - 01/2011